Epioxa’s FDA Approval Marks New Era In Corneal Cross-Linking
FDA Greenlights Glaukos’ Epioxa; Company Targets Q1 2026 Rollout Glaukos’ FDA approval for Epiox…
FDA Greenlights Glaukos’ Epioxa; Company Targets Q1 2026 Rollout Glaukos’ FDA approval for Epiox…
Flow diagram showing the studies selection process. 1. From the Cole Eye Institute (J.B.R., B.N.…
The Grosso® Reshaper is a novel, investigational medical device designed to treat Keratoconus by…
DRLT Preformed by Zaman Shah In Doughnut Refractive Lenticule Transplantation (DRLT) , a lenticu…
Sahebjada, S.; Moktar, A.A.; Vogrin, S.; Chan, E.; Baird, P.N.; Daniell, M. Does Keratoconus F…
In this video, Dr Soosan Jacab's Customised CAIRS is described. This Tissue Addition Techn…
Sun XY, Shen D, Chen HX, Cao WJ, Zhou K, Wang YN, Wang R, Wei W. Corneal surface changes afte…
CTAK by CorneaGen - A New Era in Keratoconus Care For years, Keratoconus treatment has been …